SelectQuote Receives NYSE Non-Compliance Notice Over Low Stock Price
Event summary
- SelectQuote received a notice from the NYSE indicating non-compliance with Section 802.01C due to its stock price averaging below $1.00 over a 30-trading-day period.
- The company reported strong fiscal Q2 2026 results on February 5th and secured a $415 million credit facility earlier this year.
- SelectQuote projects fiscal 2026 operating cash flow between $25 million and $35 million.
- The company has six months to cure the deficiency by achieving a closing share price of at least $1.00.
The big picture
SelectQuote's non-compliance with NYSE listing standards highlights the challenges faced by companies with low stock prices, despite strong financial performance and liquidity. The situation underscores the importance of maintaining market confidence in an increasingly competitive insurance and healthcare services sector. The company's ability to navigate this regulatory hurdle will be critical for its long-term strategic positioning.
What we're watching
- Stock Price Recovery
- Whether SelectQuote can regain compliance within the six-month cure period by achieving a $1.00 share price.
- Operational Flexibility
- How the company's strong liquidity position and cash flow outlook will support its strategy during the cure period.
- Market Perception
- The impact of the NYSE notice on investor confidence and the company's ability to maintain its listing.
Related topics